Navigation Links
OncoSec Medical to Present at the HemOnc Today Melanoma and Cutaneous Malignancies Meeting in New York
Date:3/18/2013

ry, systemic chemotherapy or immunotherapy and other treatment alternatives.  OncoSec Medical's core technology is based upon its proprietary use of an electroporation platform to dramatically enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Treatment of various solid cancers using these powerful and targeted anti-cancer agents has demonstrated selective destruction of cancerous cells while sparing healthy normal tissues during early and late stage clinical trials. OncoSec's clinical programs include three Phase II clinical trials for ImmunoPulse targeting lethal skin cancers. More information is available at http://www.oncosec.com/.

This press release contains forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward looking statements." Forward looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties which may cause our results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include our ability to raise additional funding, our ability to acquire, develop or commercialize new products, uncertainties inherent in pre-clinical studies and clinical trials, unexpected new data, safety and technical issues, competition and market conditions. These and additional risks and uncertainties are more fully described in OncoSec Medical's filings with the Securities and Exchange Commission. Undue reliance should not be placed on forward looking statements which speak only as of the date they are made. OncoSec Medical disclaims any obligation
'/>"/>

SOURCE OncoSec Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. OncoSec Medical Issues Letter to Shareholders
3. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
4. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
5. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
6. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
7. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
8. OncoSec Granted New Patent from China
9. OncoSec to Present at Upcoming Healthcare and Investor Conferences
10. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
11. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... R.I. , Aug. 21, 2014 CVS Caremark ... tender results, applicable Reference Yields and consideration payable in connection ... commenced on August 7, 2014 for (1) any and all ... All Notes") and (2) up to a maximum amount of ... 2041 and 5.750% Senior Notes due 2017 (collectively, the "Maximum ...
(Date:8/21/2014)... Aug. 21, 2014  Cyberonics, Inc. (NASDAQ: CYBX ... 2014.  Quarterly highlights 1   ... to the first quarter of fiscal 2014, and other achievements, ... an increase of 6.8%; , Strong international net sales ... currency basis; , U.S. net product sales reached a ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
Breaking Medicine Technology:CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... CITY, Mo., March 16, 2012  Argus Health Systems Inc., ... a National Council for Prescription Drug Programs (NCPDP) focus ... growing biopharmaceuticals industry. John Hill, vice ... NCPDP focus group. The NCPDP focus group, ...
... March 16, 2012 Echo Therapeutics, Inc. (Nasdaq: ... tCGM System as a non-invasive, wireless, transdermal continuous glucose ... drug delivery, today announced financial results for the year ... 10-K is available through Echo,s website at www.echotx.com ...
Cached Medicine Technology:Echo Therapeutics, Inc. Announces 2011 Financial Results 2Echo Therapeutics, Inc. Announces 2011 Financial Results 3Echo Therapeutics, Inc. Announces 2011 Financial Results 4Echo Therapeutics, Inc. Announces 2011 Financial Results 5
(Date:8/21/2014)... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast, 2012 - 2018," ... 236.1 million in 2011 and is estimated to reach ... a CAGR of 6.3% from 2012 to 2018. , ... . , Fundus cameras market growth in recent years ...
(Date:8/21/2014)... The worlds of personal care and ... chance to grab free products. BaliniSports will ... of Maine with all qualifying purchases for a limited ... friendly yoga apparel is simply perfect,” said Ada Hung, ... the two brands is intended to give people in ...
(Date:8/21/2014)... 21, 2014 Tibet has long been ... mysterious mountaintop kingdom. Prayers flags whip in the ... the low rumble of chanting monks fill the otherwise ... the world’, access to Tibet is challenging due to ... land can prove to be daunting for even the ...
(Date:8/21/2014)... David Mullings’ new book, Things #Entrepreneurs Say, ... of quotes from famous entrepreneurs to the not so ... on their challenging paths towards success. Earth Source Organics ... President and Founder Audrey Darrow alongside the bits of ... such as Oprah Winfrey, Steve Jobs, and Richard Branson, ...
(Date:8/21/2014)... 2014 Aspen Advisors, a U.S.-based healthcare consulting ... of Modern Healthcare’s Best Places to Work in Healthcare ... the healthcare industry for creating workplaces that enable employees to ... on employee responses to an employee engagement and satisfaction survey. ... has been named a “Best Places to Work in ...
Breaking Medicine News(10 mins):Health News:Fundus Cameras Market: Product Type- Mydriatic, Non-Mydriatic, Hybrid and ROP Cameras; End Users- Hospitals, Ophthalmology Clinics and Ophthalmic & Optometrist Offices 2Health News:Tom's of Maine Partner up with BaliniSports Yoga Apparel 2Health News:Earth Source Organics President Audrey Darrow Featured in New David Mullings Book 2Health News:Modern Healthcare Names Aspen Advisors Among the Top 100 Employers in the Healthcare Industry for a Fourth Consecutive Year 2
... on Series of Nationwide Investor MeetingsTUCSON, Ariz., May 8 ... ) today announced that, in connection with management,s upcoming meetings ... Securities and Exchange Commission its Spring 2009 Investor Presentation. ... free at the SEC,s website at http://www.sec.gov ...
... The federal government has made tax incentives accessible for ... implementation of simple automation into new or existing facilities ... a positive impact on organizations purchasing automated carousels and ... efficiencies and a high internal rate of return. The ...
... Six-Fold and Recurring Handpiece Sales Increase 22% on Comparable ... (OTC Bulletin Board: MLSS), the recognized leader in advanced ... for the three months ended March 31, 2009. ... 2009 with Three Months Ended March 31, 2008: ...
... N.J., May 8 Quest Diagnostics Incorporated (NYSE: ... and services, will conduct its annual meeting of shareholders on ... webcast will be accessible through the Investor Relations section of ... For those unable to listen to the live broadcast, ...
... Inc. (NTI(R)) (Nasdaq: NTII ) today announced ... March 31, 2009.Revenues for the third quarter of fiscal ... the third quarter of fiscal 2008. Research and development ... March 31, 2009 compared to $5.9 million for the ...
... Universal Capital Management, Inc. (OTC Bulletin Board: ... provides management and strategic growth resources to emerging ... Corporation ("Vystar") and Alatech Healthcare, LLC announced 510(k) ... (FDA) to market and sell Alatech,s Envy(TM) condom ...
Cached Medicine News:Health News:Providence Service Corporation Makes Its Spring 2009 Presentation Publicly Available 2Health News:Providence Service Corporation Makes Its Spring 2009 Presentation Publicly Available 3Health News:Providence Service Corporation Makes Its Spring 2009 Presentation Publicly Available 4Health News:Providence Service Corporation Makes Its Spring 2009 Presentation Publicly Available 5Health News:Providence Service Corporation Makes Its Spring 2009 Presentation Publicly Available 6Health News:Milestone Scientific Reports Strong Sales Growth in First Quarter 2009 Results 2Health News:Milestone Scientific Reports Strong Sales Growth in First Quarter 2009 Results 3Health News:Milestone Scientific Reports Strong Sales Growth in First Quarter 2009 Results 4Health News:Milestone Scientific Reports Strong Sales Growth in First Quarter 2009 Results 5Health News:Milestone Scientific Reports Strong Sales Growth in First Quarter 2009 Results 6Health News:Milestone Scientific Reports Strong Sales Growth in First Quarter 2009 Results 7Health News:Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial Results 2Health News:Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial Results 3Health News:Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial Results 4Health News:Universal Capital Management Reports Vystar(TM) Corporation Receives FDA Clearance for Envy(TM) Natural Rubber Latex Condom Made with Vytex(TM) NRL 2Health News:Universal Capital Management Reports Vystar(TM) Corporation Receives FDA Clearance for Envy(TM) Natural Rubber Latex Condom Made with Vytex(TM) NRL 3Health News:Universal Capital Management Reports Vystar(TM) Corporation Receives FDA Clearance for Envy(TM) Natural Rubber Latex Condom Made with Vytex(TM) NRL 4
Desmarres Retractor Size 4...
Desmarres Lid Retractor thin solid blades. Size 2....
... system introduces a new level ... microsurgical instrumentation. It has an ... with advanced microcomputer control of ... operate with a full range ...
Multiple Modulation Phaco (MMP) programmability with eight surgeon settings for maximum versatility. The combination of the peristaltic power balanced pump and the piezoelectric handpiece results in ...
Medicine Products: